These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma. Goers TA; Abdo M; Moley JF; Matthews BD; Quasebarth M; Brunt LM Surg Endosc; 2013 Feb; 27(2):428-33. PubMed ID: 22936431 [TBL] [Abstract][Full Text] [Related]
27. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233 [TBL] [Abstract][Full Text] [Related]
34. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center. Falhammar H; Kjellman M; Calissendorff J Endocrine; 2018 Dec; 62(3):566-575. PubMed ID: 30220006 [TBL] [Abstract][Full Text] [Related]
35. Genetic Variants in Patients with Multiple Head and Neck Paragangliomas: Dilemma in Management. Guha A; Vicha A; Zelinka T; Musil Z; Chovanec M Biomedicines; 2021 May; 9(6):. PubMed ID: 34072806 [TBL] [Abstract][Full Text] [Related]
36. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. Lendvai N; Pawlosky R; Bullova P; Eisenhofer G; Patocs A; Veech RL; Pacak K Endocrinology; 2014 Jan; 155(1):27-32. PubMed ID: 24189137 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085 [TBL] [Abstract][Full Text] [Related]
38. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. Calissendorff J; Juhlin CC; Bancos I; Falhammar H Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205664 [TBL] [Abstract][Full Text] [Related]
39. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study. Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261 [TBL] [Abstract][Full Text] [Related]
40. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study. Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]